Recent News

574 News Items found
Metastatic tumor in the lung, with different colors used to represent the cell nuclei, the blood vessels, and the P-selectin protein.
In the Lab
A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.
Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.
Announcement
Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
a sneaky man on a sneaky mission
In the Lab
Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
photo of Foxo1 protein stained in regulatory T cells
In the Lab
The immune system is a powerful tool for fighting cancer — sometimes too powerful.
Cellular sphere that is purple and lit throughout by yellow-orange light.
Snapshot
MSK nanotechnology researchers have developed an innovative approach for measuring the permeability of living tumors.
Pictured: Casper zebrafish
In the Lab
Hail to the zebrafish. MSK scientists are using a small fish to answer some big questions about cancer.
Light micrograph of white blood cells from a patient with acute myeloid leukemia.
In the Lab
An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.
Montage of beer, reproducing cells, and building blocks
Feature
MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.
In the Lab
Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?